Acurx Pharmaceuticals, Inc. Banner Image

Acurx Pharmaceuticals, Inc.

  • Ticker ACXP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Acurx Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Staten Island , New York
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early-stage antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistantMore Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP).
5.0 / 5.0 (1)

Acurx Pharmaceuticals, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Acurx Pharmaceuticals, Inc.

Most Recent Annual Report

Acurx Pharmaceuticals, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Acurx Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!